News Daily News Thwarted Access to PCSK9 Inhibitors Linked to Greater Risk of Major CV Events Marcus A. Banks July 25, 2019
News Daily News Higher Risk of Atrial Fibrillation in Retired Football Players Michael O'Riordan July 25, 2019
News Daily News Smoking More Strongly Linked to Long-term Risks of PAD Than to Other Types of CVD Todd Neale July 24, 2019
News Daily News CV Risk Factors in Youth May Prove Indelible for Later CAD Marcus A. Banks July 17, 2019
News Conference News SCCT 2019 Time to Ease Up on Prior Authorization for PCSK9 Inhibitors? Yael L. Maxwell July 15, 2019
News Daily News Most Supplements and Diets Don’t Lower CVD or Mortality Risks Michael O'Riordan July 09, 2019
News Daily News High Levels of Lp(a) Linked to Increased Ischemic Stroke Risk Michael O'Riordan July 01, 2019
News Daily News Vitamin D for CV Risk? Think Twice, Meta-analysis Confirms Marcus A. Banks June 21, 2019
News Daily News CAD’s Genetic Basis Strongly Overlaps With Other Vascular Conditions and Risk Factors Caitlin E. Cox June 12, 2019
News Conference News EAS 2019 Absence of FH Diagnosis Linked to Increased Risk of Premature Mortality Michael O'Riordan June 05, 2019
News Conference News SCAI 2019 LDL Apheresis Potentially a ‘Head Start’ to Conventional Lipid-Lowering Methods Post-PCI in ACS: PREMIER Yael L. Maxwell June 03, 2019
News Conference News EuroPCR 2019 ROBOT-ACS: Real-World Data Reiterate Ticagrelor’s Safety L.A. McKeown May 31, 2019
News Conference News EAS 2019 Clear CVD Risk Reduction With PCSK9 Inhibitors, but No Mortality Effect: Meta-analysis Michael O'Riordan May 28, 2019
News Daily News Higher Risk of Intracranial Hemorrhage With Aspirin in Primary Prevention Michael O'Riordan May 20, 2019
News Daily News Residual Inflammatory Risk and PCI: Worthy Biomarker or Merely Something Else to Measure? Yael L. Maxwell May 15, 2019
News Daily News Bariatric Surgery Linked to Survival Advantage After MI and CVA Michael O'Riordan May 13, 2019
News Daily News Elevations in hs-cTnI Linked to Higher Risk of CVD, Particularly Heart Failure Michael O'Riordan May 06, 2019
News Daily News PCSK9 Inhibitor Alirocumab Receives Expanded Indication for CV Event Reduction Michael O'Riordan April 29, 2019